welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
Prognostic Factors Affecting Duchenne Muscular Dystrophy
study id #: NCT03372655
condition: Duchenne Muscular Dystrophy
status: not yet recruitingpurpose:
Determination of prognostic factors affecting ambulation of duchenne muscular dystrophy
mechanism of action: No pharmaceutical intervention
last updated: November 22, 2018
start date: January 1, 2018
estimated completion: January 1, 2019
size / enrollment: 82
Duchenne muscular dystrophy is the most common herditary muscular disease , it lead to loss of ambulation in early teenageers . It lead to early death at the mean age of 19 years
- Ten meter walking test [Time Frame: 2018 - 2019]
- Muscle strength [Time Frame: 2018- 2019]
Any male pt diagnosed as Duchenne muscular dystrophy by typical clinical picture & shooting serum CPK level & EMG study or biopsy & age 10 to 18yrs old
Female patient' age below 10 yrs old or above 18 yrs old. Patient with autoimmune disease or malignancy.
The Use of Speckle Tracking Echocardiography for Early Detection of Myocardial Dysfunction in Patients with Duchenne...Cardiac complications are the leading ca...
DMD clinical therapies II: P.133 The burden of participation in a clinical trial for boys with Duchenne muscular dys...Despite some medical breakthroughs in Du...
Optimum Insufflation Capacity in NMDPatients with underlying neuromuscular d...
Evaluation of Muscle miRNA as Biomarkers in DystrophinopathiesDuchenne muscular dystrophy (DMD), cause...
Catabasis Pharmaceuticals Announces Publication Of Phase 1 Clinical Results Of Edasalonexent (CAT-1004) In Duchenne ...Catabasis Pharmaceuticals, Inc., a clini...
Antisense Therapeutics to commence muscular dystrophy trialsAntisense Therapeutics is planning to un...
Association between specific dystrophin gene mutations and myocardial fibrosis by cardiovascular magnetic resonance ...Background Duchenne (DMD) and Becker (B...